The expression of CD44 receptor is not affected by miR-146a treatment, In contrast, TLR-4 expression and NF-kB activation are changed, which may help to develop new treatment strategies to reduce the incidence rate of OA and RA. The gene discussed is NFKB1; the disease is rheumatoid arthritis.